ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1214

Using Patient Self-Reported Measures to Predict All-Cause Hospitalization in a Population-Based Lupus Cohort

S. Sam Lim1, Sandra Wu2, Ryan Ross3, Gaobin Bao1, Megan Richards3, Liisa Palmer3 and Gary Bryant4, 1Emory University, Atlanta, GA, 2AstraZeneca, Hockessin, DE, 3Merative, Cambridge, MA, 4AstraZeneca, New Castle, DE

Meeting: ACR Convergence 2023

Keywords: Patient reported outcomes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1200–1220) Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that affects the skin, joints, kidneys, lungs, central nervous system, and hematopoietic system. As a result of disease activity, patients with SLE have a 2- to 3-fold increased risk of hospitalization compared with the general population. Previous research has aimed to identify potential biomarkers or clinical factors that could be used to predict SLE flares that correlate with hospitalizations, but to date there has been little consistency. The purpose of this study was to develop a patient-centric predictive model that can be easily integrated into the clinical setting to identify patients that are at a higher risk for hospitalization.

Methods: Georgians Organized Against Lupus (GOAL) is a Centers for Disease Control and Prevention supported population-based cohort of validated SLE patients in Atlanta who complete annual surveys. From two surveys (2011-13), demographic, social-economic, clinical information and self-reported outcomes including Short-Form Survey (SF-12) and the SLE Activity Questionnaire (SLAQ) were obtained. This database was linked with the Georgia Hospital Discharge Database to obtain all-cause hospitalizations within 6 months of each survey. Those who died during a hospitalization were censored at the time of death.

Following descriptive analyses, a multivariable model examined the predictors of interest and all-cause hospitalization. Automated variable selection methods, the lowest Akaike Information Criterion (AIC) and selection through penalized regression (LASSO), were used. Variables of low importance across methods were excluded from further analysis. A classification and regression tree (CART) model generated a decision tree for predicting hospitalization risk based on a combination of components from SLAQ, SF-12, and sociodemographic characteristics.

Results: Of the 1,486 GOAL responses, 186 (12.5%) had an all-cause hospitalization within 6-months after survey completion. The mean age at survey completion was 47 (SD: 13), 94% of patients were female, 78% of patients were Black, and had SLE for 14 (9) years (Table 1). CART modeling identified patients with weight loss, fatigue, and Raynaud’s symptoms as having the highest probability of having a hospitalization within 6 months (Pr=33.6%) (Figure1). Among those without weight loss, an increased probability of hospitalization was seen among those that had a poverty ratio < 1.5 and had more than 75% activity impairment due to health (Pr=21.3%).

Conclusion: In a population-based SLE cohort with a large proportion of Black patients, those who had weight loss, fatigue, and Raynaud’s symptoms in the previous 3 months were at high risk of being hospitalized within the next 6 months. Collection of these symptoms that may not often be deemed clinically significant can be utilized in the clinical setting to identify SLE patients at higher risk of hospitalization and guide providers and patients accordingly.

Supporting image 1

Supporting image 2


Disclosures: S. Lim: None; S. Wu: AstraZeneca, 3; R. Ross: None; G. Bao: None; M. Richards: None; L. Palmer: None; G. Bryant: AstraZeneca, 3.

To cite this abstract in AMA style:

Lim S, Wu S, Ross R, Bao G, Richards M, Palmer L, Bryant G. Using Patient Self-Reported Measures to Predict All-Cause Hospitalization in a Population-Based Lupus Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/using-patient-self-reported-measures-to-predict-all-cause-hospitalization-in-a-population-based-lupus-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-patient-self-reported-measures-to-predict-all-cause-hospitalization-in-a-population-based-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology